| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |